Viewing data from:

DOFETILIDE

ANDA

DOFETILIDE | A208625 | BIONPHARMA INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: TIKOSYN(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.1953

per ea

Lowest NADAC/Unit

$0.1887

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69452013117DOFETILIDE 125 MCG CAPSULE	$0.1953	EA	Generic	—	2026-06-17
69452013217DOFETILIDE 250 MCG CAPSULE	$0.1933	EA	Generic	—	2026-06-17
69452013317DOFETILIDE 500 MCG CAPSULE	$0.1887	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain10 active DMFs1 inactive

10 active API suppliers hold Drug Master Files for this ingredient.

MATRIX PHARMACORP PRIVATE LTDDOFETILIDE USP, POLYMORPH P162B

DMF 297222015

INDUSTRIALE CHIMICA SRLDOFETILIDE USP

DMF 300422015

APITORIA PHARMA PRIVATE LTDDOFETILIDE USP

DMF 305602016

CHEMWERTH INCDOFETILIDE USP

DMF 307182017

SUN PHARMACEUTICAL INDUSTRIES LTDDOFETILIDE USP

DMF 310262016

MSN LIFE SCIENCES PRIVATE LTDDOFETILIDE USP

DMF 311582016

EMCURE PHARMACEUTICALS LTDDOFETILIDE USP

DMF 318112017

FARMAK ASDOFETILIDE

DMF 318582017

ENALTEC LABS PRIVATE LTDDOFETILIDE USP

DMF 319392018

INTAS PHARMACEUTICALS LTDDOFETILIDE USP

DMF 333052018

BIDDLE SAWYER PHARMA LLCInactiveDOFETILIDE USP

DMF 305082016

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 0.125MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Apr 10, 2018

No patent or exclusivity listings for this strength.

#002 — 0.25MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Apr 10, 2018

#003 — 0.5MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Apr 10, 2018